Finance

Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
24,76 CN¥
+0,41%
(+0,10) 1D
15 қаз., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
24,52 CN¥
High
24,90 CN¥
Low
24,43 CN¥
Mkt. cap
33,45 млрд
Avg. vol.
4,48 млн
Volume
9,96 млн
Dividend
2,02%
Quarterly dividend
0,12 CN¥
Ex-dividend date
2026 ж. 01 шіл.
P/E ratio
35,01
52-wk high
35,87 CN¥
52-wk low
21,87 CN¥
EPS
0,71 CN¥
Shares outstanding
1,37 млрд
No. of employees
17 мың
Open
24,52 CN¥
High
24,90 CN¥
Low
24,43 CN¥
Mkt. cap
33,45 млрд
Avg. vol.
4,48 млн
Volume
9,96 млн
Dividend
2,02%
Quarterly dividend
0,12 CN¥
Ex-dividend date
2026 ж. 01 шіл.
P/E ratio
35,01
52-wk high
35,87 CN¥
52-wk low
21,87 CN¥
EPS
0,71 CN¥
Shares outstanding
1,37 млрд
No. of employees
17 мың
News stories
From web sources and news partners
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17,3 мың
Founded1669
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
3,54 млрд
3,95 млрд
4,66 млрд
3,72 млрд
Cost of goods sold
1,97 млрд
2,50 млрд
2,72 млрд
2,17 млрд
Cost of revenue
1,97 млрд
2,50 млрд
2,72 млрд
2,17 млрд
Research and development expenses
53,41 млн
144,52 млн
51,64 млн
74,50 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,10 млрд
1,30 млрд
1,13 млрд
1,04 млрд
Operating expense
1,16 млрд
1,52 млрд
1,23 млрд
1,16 млрд
Total operating expenses
3,13 млрд
4,02 млрд
3,95 млрд
3,33 млрд
Operating income
408,67 млн
-73,33 млн
709,73 млн
383,76 млн
Other non operating income
-3,64 млн
-4,50 млн
-3,96 млн
-4,53 млн
EBT including unusual items
346,57 млн
67,54 млн
748,37 млн
431,21 млн
EBT excluding unusual items
418,62 млн
-56,72 млн
750,60 млн
414,06 млн
Income tax expense
88,79 млн
27,32 млн
131,64 млн
112,60 млн
Effective tax rate
25,62%
40,44%
17,59%
26,11%
Other operating expenses
-1,80 млн
58,15 млн
29,98 млн
47,32 млн
Net income
232,06 млн
11,82 млн
471,18 млн
255,01 млн
Net profit margin
6,56%
0,30%
10,10%
6,86%
Earnings per share
-
-
-
-
Interest and investment income
45,55 млн
48,93 млн
70,91 млн
59,45 млн
Interest expense
-30,03 млн
-28,19 млн
-26,08 млн
-24,57 млн
Net interest expenses
15,52 млн
20,74 млн
44,83 млн
34,88 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
495,57 млн
18,15 млн
801,21 млн
477,52 млн
Gain or loss from assets sale
1,87 млн
-25,11 млн
-
-10,41 млн
AI content may include mistakes. Learn more
Google қолданбалары